Previous studies show that in the case of algae, motile cilia work like arms on a swimmer, to help algae reach sunlight, which they use to make sugar for energy and survival. Motile cilia can make 40-50 whip-like motions per second and are continuously being resorbed and replaced. These motile cilia also inhabit a type of support brain cell called ependymal cells; the cells that line the cavities of the brain containing cerebrospinal fluid which nourishes and cleanses the brain.
Earlier studies from the lab were the first to show that ceramide is present in these fast-moving algae cilia where it has likely been at work for a billion years. The group reasoned that algae, an old and simple plant, seemed a good first model to figure out what regulates cilia. Cilia in algae are comparatively big, about 10 times those in mammalian cells, so with just a regular microscope, the researchers could easily watch cilia movement. The current study showed that when they applied even a miniscule amount of a fungus toxin known to inhibit ceramide production, the usually agile algae stopped, the cilia shrank and some fell off.
The current study shows that one of the protein kinases that is highly conserved from Chlamydomonas to mammals and critical for ciliogenesis is glycogen synthase kinase-3 (GSK3). The lab explain that in Chlamydomonas an GSK3 isoform regulates flagellar length. Results show that ceramide present in the cilia of human ependymal cells activates GSK3 to regulate cilia. The researchers conclude that in both algae and ependymal cells, the two can be found together and, without their teamwork, hydrocephalus, excess fluid on the brain, can result.
The team surmise that their findings suggest that if ceramide is one of the key regulators of cerebrospinal fluid movement, it may also be a drug target to help normalize the function of cilia. For the future, the researchers plan to visualize cilia movement in ependymal cells.
Source: University of Georgia
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.